LifeMD, Inc. (LFMD) stock

LFMDNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as LFMDP

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 12/3025% below fair value

$1.66−0.13 (-7.02%)

Close on Nov 12, 2026Market cap $79.77MP/E –Yield –

LifeMD r&d expenses

Research and development expenses are spending on new products and technology.

For fiscal 2015 it was $23.93K.

Period	Period end	Value	Change
FY2015	Dec 31, 2015	$23.93K	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is LFMD.

Revenue growth23.6% · median -2.4%

Gross margin86.5% · median 66.2%

Operating margin-11.0% · median -4.7%

Net margin0.2% · median -6.3%

Advertisement
300 × 250

See a number that looks wrong?